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Although the molecular basis of pseudohypoparathyroidism type 1b (PHP type 1b) remains unknown, a defect in
imprinting at the GNAS1 locus has been suggested by the consistent finding of paternal-specific patterns of DNA
methylation on maternally inherited GNAS1 alleles. To characterize the relationship between the genetic and
epigenetic defects in PHP type 1b, we analyzed allelic expression and methylation of CpG islands within exon 1A
of GNAS1 in patients with sporadic PHP type 1b and in affected and unaffected individuals from five multi-
generational kindreds with PHP type 1b. All subjects with resistance to parathyroid hormone (PTH) showed loss
of methylation of the exon 1A region on the maternal GNAS1 allele and/or biallelic expression of exon 1A–
containing transcripts, consistent with an imprinting defect. Paternal transmission of the disease-associatedhaplotype
was associated with normal patterns of GNAS1 methylation and PTH responsiveness. We found that affected and
unaffected siblings in one kindred had inherited the same GNAS1 allele from their affected mother, evidence for
dissociation between the genetic and epigenetic GNAS1 defects. The absence of the epigenetic defect in subjects
who have inherited a defective maternal GNAS1 allele suggests that the genetic mutation may be incompletely
penetrant, and it indicates that the epigenetic defect, not the genetic mutation, leads to renal resistance to PTH in
PHP type 1b.
Introduction
Pseudohypoparathyroidism (PHP), the first human dis-
order of hormone resistance to be identified (Albright et
al 1942), is characterized by biochemical hypoparathy-
roidism (i.e., hypocalcemia and hyperphosphatemia) due
to parathyroid hormone (PTH) resistance rather than
PTH deficiency. Two genetically distinct forms of PHP
type 1 have been described (Levine et al. 1980). The more
common variant, termed “PHP type 1a” (MIM 30080
and MIM 103580), is an autosomal dominant, pleiotro-
pic disorder with resistance to multiple hormones (PTH,
thyroid-stimulating hormone [TSH], luteinizing hormone
[LH], growth hormone–releasing hormone [GHRH])
and a constellation of developmental defects termed
“Albright’s hereditary osteodystrophy” (AHO) (Albright
et al. 1942). Patients with PHP type 1a have mutations
in maternal GNAS1 alleles that abrogate expression or
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activity of Gs, the heterotrimeric G protein (Farfel et al.
1980a, 1980b, 1982; Levine et al. 1980, 1983b; Downs
et al. 1983) that couples receptors to activation of ad-
enylyl cyclase (Levine et al. 1983a; Namnoum et al. 1998;
Kaartinen et al 1994). By contrast, identical mutations in
paternal alleles are associated with AHO and normal hor-
mone responsiveness, a variant termed “pseudopseudo-
hypoparathyroidism” (PPHP), which results from tissue-
specific genomic imprinting at this locus.
PHP type 1b (MIM #603233) is a clinically distinct
variant of PHP that is also linked to the GNAS1 locus
(Juppner et al. 1998; Bastepe et al. 2001b; Jan de Beur
et al. 2003). Subjects with PHP type 1b lack features
of AHO, show renal resistance to PTH as the only man-
ifestation of hormone resistance, and have normal Gsa
activity in accessible tissues (Jan de Beur and Levine
2001). Subjects with PHP type 1b have paternal-specific
patterns of cytosine methylation within differentially
methylated regions (DMR) of maternally inherited
GNAS1 alleles (Liu et al. 2000a; Bastepe et al. 2001b),
suggesting that an imprinting defect that affects ex-
pression of GNAS1 in the proximal renal tubule is the
basis of this disorder; however, the specific genetic mu-
tation(s) that accounts for this epigenetic defect is un-
known. In the present study, we show that loss of im-
printing of exon 1A on maternal GNAS1 alleles is a
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consistent finding in DNA from peripheral blood leu-
kocytes and transformed lymphoblast cell lines of sub-
jects with sporadic or inherited PHP type 1b. Remark-
ably, some subjects who inherit a defective maternal
GNAS1 allele do not manifest an imprinting defect,
which implies that the genetic mutation may be incom-
pletely penetrant. The presence of normal PTH respon-
siveness in these subjects indicates that the epigenetic
defect, not the genetic mutation, is predictive of the
development of renal resistance to PTH in PHP type 1b
Methods
Patients
The five kindreds with PHP type 1b studied in this
project have been described elsewhere (Jan de Beur et
al. 2003). The clinical and biochemical characteristics
of affected members, as well as six additional subjects
with sporadic PHP type 1b, met the criteria for PHP
type 1b as described elsewhere (Levine et al. 1980,
1983a; Jan de Beur and Levine 2001, Jan de Beur et al.
2003). The diagnosis of PHP type 1b was established in
family R by evidence of PTH resistance (hypocalcemia
or normocalcemia with elevated serum levels of intact
PTH), absence of features of AHO, normal responsive-
ness to TSH, absence of evidence of vitamin D deficiency
or hypomagnesemia, and normal sequence of 13 coding
exons and exon/intron boundaries of the GNAS1 gene.
The Joint Committee on Clinical Investigation of The
Johns Hopkins University School of Medicine approved
the study protocol, and written informed consent was
obtained from all subjects or their parents.
DNA Analyses
For GNAS1 gene analysis, DNA was extracted from
peripheral blood leukocytes by standard methods (Sam-
brook et al. 1989), and the nucleotide sequence of exons
1–13, the flanking exon/intron boundaries, the exon 1
promoter region, and exon 1A were analyzed as de-
scribed elsewhere (Jan de Beur et al. 1998, 2003).
For restriction analysis, 10-mg aliquots of genomic
DNA were digested with the indicated restriction en-
zymes (New England Biolabs). Products were separated
on 1.5% agarose gels (SeaKem, FMC Bioproducts),
transferred to nylon membranes, and hybridized to a
32P-radiolabeled genomic fragment of GNAS1 (nucleo-
tides 29078–29993 of chromosome 20q [GenBank ac-
cession number AL121917]). Hybridization signals were
detected with a BioRad PhosphorImager or on Kodak
XAR film.
Bisulfite-Modified Methylation Analysis of GNAS1
DNA (1 mg) was digested with 20 U EcoRI (at 37C
for 2 h) and denatured (in 3M NaOH at 37C for 15
min, then at 95C for 3 min); 400 ml of sodium bisulfite
solution (Nagane et al. 2000) was added and incubated
at 55C for 20 h. The DNA was desalted using the Wiz-
ard DNA Clean-Up system (Promega). Bisulfite-treated
DNA was subjected to methylation-specific nested PCR,
to amplify GNAS1 sequences, using primers and PCR
conditions as described in table A (online only). PCR
products were gel purified and sequenced using the USB
Radiolabeled Terminator Cycle Sequencing kit (USB).
RT-PCR Analysis of GNAS1 Expression
First, strand cDNA was synthesized from total RNA
from fresh lymphocytes or cultured Epstein-Barr virus–
transformed lymphoblasts with Superscript II (Invitro-
gen). PCR was performed with specific forward primers
that anneal to nucleotide sequences in alternative first
exons corresponding to NESP55, XLas, exon 1A, and
Gsa transcripts, plus a reverse primer that corresponds
to exon 6 sequences, to include a common exon 5 (Ala
131) polymorphism. (PCR primer pairs and conditions
are listed in table A [online only].) PCR products were
gel purified and sequenced using the USB Radiolabeled
Terminator Cycle Sequencing kit (USB).
Results
Imprinting of Alternative First Exons of GNAS1
Differential methylation of cytosines within specific
sequences of the GNAS1 locus has been implicated as
the basis of monoallelic expression of NESP55, XLas,
and exon 1A transcripts (Hayward et al. 1998a,1998b;
Liu et al. 2000a). We used restriction endonuclease di-
gestion to determine the methylation status of the exon
1A DMR region in subjects with sporadic and familial
PHP type 1b. A probe spanning the exon 1A DMR was
hybridized to genomic DNA digested with PstI alone or
with PstI plus the methylation-sensitive restriction en-
zyme NgoMIV (fig. 1). Digestion of DNA samples from
unaffected family members, PHP1b carriers, unaffected
subjects, or patients with PHP type 1a with PstI pro-
duced a single 2.8-kb band; and digestion with both PstI
and NgoMIV generated a 2.8-kb band of ∼50% inten-
sity, plus three smaller bands, two of which (1.4 and 1.2
kb) were visible on the autoradiograms, representing di-
gestion at unmethylated NgoMIV sites in the exon 1A
region. This pattern is consistent with methylation of
exon 1A on the maternal GNAS1 allele and lack of
methylation on the paternal GNAS1 allele. By contrast,
digestion of DNA samples from patients with familial
or sporadic PHP type 1b with both NgoMIV and PstI
resulted in complete loss of the 2.8-kb band, indicating
that the NgoMIV sites on both alleles were unmethylated
and susceptible to cleavage (fig. 1). These results are
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Figure 1 Exon 1A methylation status revealed by restriction digestion of genomic DNA. Genomic DNA was digested with PstI alone or
PstI plus NgoMIV, which cuts only unmethylated sequences. Digests were transferred to nylon membranes and hybridized to a radiolabeled
genomic DNA probe corresponding to exon 1A of GNAS1. A representative autoradiogram (top) indicates results of individuals from family
R labeled with the pedigree number corresponding to figure 4. Bottom, positions of the recognition sites for the two restriction enzymes with
respect to exon 1A (striped box), along with the corresponding position of the 900-bp probe. Digestion of DNA from unaffected individuals
with PstI generates a single, 2.8-kb fragment from both alleles, whereas digestion with both PstI and NgoMIV yields a 2.8-kb fragment from
the maternal (methylated) allele and fragments of 1.4 kb, 1.2 kb, and 90 bp (not shown) from the paternal (unmethylated) allele. Digestion of
DNA from subjects with PHP type 1b with PstI yields a single fragment of 2.8-kb, but after digestion with PstI plus NgoM IV there is complete
loss of the 2.8-kb fragment, indicating that both alleles are unmethylated within the DMR of exon 1A (see text).
consistent with a loss of methylation of the exon 1A
region of the maternal GNAS1 allele.
Bisulfite Sequencing of GNAS1
Exon 1A sequences were analyzed after treatment of
DNA with sodium bisulfite, to examine cytosine meth-
ylation more comprehensively. We performed methyla-
tion-sensitive PCR, using oligonucleotide primers that
were designed to anneal to sequences containing cytosine
residues that were certain to be converted to uracil by
sodium bisulfite treatment because they do not occur in
CpG dinucleotides. Bisulfite-treated DNA from control
subjects revealed a 50% reduction in the intensity of
cytosine bands within CpG dinucleotides of exon 1A,
consistent with methylation of only one allele (fig. 2).
By contrast, bisulfite-treated DNA from subjects with
PHP type 1b showed conversion of all C bands to T
bands, indicating that both GNAS1 alleles were un-
methylated at CpG positions within exon 1A (fig. 2).
Expression of GNAS1 Alleles by RT-PCR Analysis
To evaluate allelic expression of GNAS1 transcripts
generated from the promoter regions for NESP55, XLas,
exon 1A, and Gsa, we performed RT-PCR using RNA
from individuals who were heterozygous for a poly-
morphism (T/C) within GNAS1 exon 5. Unaffected sub-
jects and patients with PHP 1a showed uniallelic ex-
pression for transcripts corresponding to NESP55, XLas,
and exon 1A, and biallelic expression of Gsa transcripts
(fig. 3; table 1). Similar RT-PCR analyses in subjects with
PHP type 1b who were heterozygous for polymorphisms
in either GNAS1 exon 5 or exon 1A (Liu et al. 2000a;
Jan de Beur et al. 2003) showed biallelic expression in
exon 1A in all subjects with familial or sporadic PHP type
1b. Expression of NESP55 was uniallelic in all subjects,
and expression of XLas was uniallelic in five of six sub-
jects. Expression of Gsa was biallelic in all tested indi-
viduals. The biallelic expression of exon 1A was a heri-
table epigenetic trait and was completely concordant with
the presence of PTH resistance in subjects with PHP type
1b (fig. 4; table 1).
Inheritance and Penetrance of the GNAS1
Epigenotype
In an earlier study, we used linkage analysis to map
the genetic defect causing autosomal dominant PHP type
1b in these five kindreds to a region of chromosome
20q13 that includes part of GNAS1 (Jan de Beur et al.
2003). All subjects with PTH resistance in these five
kindreds showed evidence of the PHP type 1b epigenetic
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Figure 2 Bisulfite sequencing of exon 1A of GNAS1. Autoradiograms showing the nucleotide sequence of a portion of GNAS1 exon 1A
after bisulfite treatment of genomic DNA in unaffected subjects, a PHP1b carrier (*), and subjects with PHP1b from family R, identified with
pedigree numbers corresponding to figure 4. PCR products were directly sequenced, to avoid quantitative errors that might arise because of
different cloning efficiencies (see text), and thus represent sequences derived from maternal and paternal alleles. The sequence ladder from the
unaffected and carrier subject shows both Cs and Ts at multiple positions, corresponding to cytosines within CpGs that were methylated
(maternal allele) or unmethylated (paternal allele), respectively. By contrast, the sequence ladder from the subjects with PHP type 1b shows
only Ts, indicating that cytosines on both maternal and paternal alleles were unmethylated.
abnormality in GNAS1, as documented by loss of meth-
ylation of exon 1A on the maternal GNAS1 allele and/
or biallelic expression of exon 1A–containing transcripts
(fig. 4; table 1). Moreover, affected subjects had a ma-
ternally inherited disease-associated haplotype, whereas
unaffected subjects who were obligate gene carriers had
inherited the same haplotype paternally, consistent with
a model of maternal-specific transmission of PTH resis-
tance due to presumed tissue-specific imprinting of the
Gsa promoter (Juppner et al. 1998; Liu et al. 2000a;
Bastepe et al. 2001b; Germain-Lee et al. 2002; Man-
tovani et al. 2002). These results are consistent with
complete concordance between the epigenetic defect and
PTH resistance.
By contrast, analysis of pedigree R (fig. 4) provides
evidence for dissociation between maternal transmission
of the disease-associated locus and the epigenetic
GNAS1 defect. Specifically, members of the same sibship
show either PTH resistance (subject II.4) or PTH re-
sponsiveness (subjects II.2 and II.6), despite having in-
herited the same GNAS1 allele from their mother (fig.
4) (Jan de Beur et al. 2003). That this is not a result of
an undetected genetic rearrangement or conversion in
the maternal allele inherited by subjects II.2 and II.6 is
demonstrated by the subsequent transmission of this al-
lele to subject II.2’s two children, subjects III.1 and III.3,
both of whom exhibit PTH resistance and the epigenetic
GNAS1 methylation. Remarkably, subject IV.2, who in-
herited the disease-associated GNAS1 allele from his
affected mother (subject III.1), also lacks the epige-
netic methylation defect. As expected from his normal
epigenotype, subject IV.2 has normal PTH responsive-
ness at age 4 years. However, in some cases, hormone
resistance in PHP 1a may manifest after age 5 years.
Thus, the genetic mutation that is presumed to alter
imprinting at the GNAS1 locus exhibits incomplete pen-
etrance and results in inconsistent acquisition of a pater-
nal epigenotype on a maternal GNAS1 allele.
Discussion
Genomic imprinting results from an epigenetic modifi-
cation of a gene or the chromosome on which it resides
that leads to the preferential expression of a specific allele
in somatic tissues according to parental origin (Reik and
Walter 2001). In most cases, imprinting is a reversible
process, because the previous parental imprint is re-
quired to switch in the germline of progeny of the
opposite sex. Thus, establishment and maintenance of
genomic imprints are critical, and abnormalities in im-
printing can result in genetic disorders that do not con-
form to traditional modes of Mendelian inheritance.
GNAS1 produces a variety of sense and antisense
transcripts that exhibit reciprocal imprinting (Weinstein
et al. 2001). Four alternative first exons splice onto a
common set of 12 downstream exons to generate dis-
tinct products. Transcripts that contain exon 1 encode
Gsa, whereas transcripts containing alternative, up-
stream first exons encode XLas and NESP55 (Hayward
et al. 1998a, 1998b; Hayward and Bonthron 2000).
Transcripts that contain a third alternative first exon,
termed “1A,” are apparently untranslated (Swaroop et
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Figure 3 RT-PCR expression analysis of GNAS1 exon 1A. Total RNA from fresh peripheral blood leukocytes or transformed lymphoblasts
was reverse transcribed and amplified using an exon 1A–specific upstream primer and an exon 6 downstream primer. Direct sequencing of the
RT-PCR products is shown for subjects who are heterozygous for a common T/C polymorphism in exon 5. The normal individuals show
uniallelic expression of exon 1A transcripts, as indicated by either the C or T (arrow in the sequence ladder) at the polymorphic nucleotide
site, indicating expression from only the paternal allele. By contrast, the subject with PHP type 1b shows both the C and T nucleotides, indicating
biallelic expression of exon 1A.
al. 1991). NESP55 is expressed exclusively from the
maternal allele, whereas XLas (Hayward et al. 1998a,
1998b) and exon 1A (Liu et al. 2000b) transcripts are
expressed only from the paternal allele. Expression of
Gsa is biallelic in most tissues (Campbell et al. 1994;
Hayward et al. 1998a, 1998b; Zheng et al. 2001), but
recent studies show that preferential expression of the
maternal allele occurs in human pituitary (Hayward et
al. 2001), human thyroid (Germain-Lee et al. 2002;
Mantovani et al. 2002), and human ovary (Mantovani
et al. 2002), and in proximal tubule cells from mice in
which one Gnas allele is disrupted (Schwindinger et al.
1998; Yu et al. 1998; Weinstein et al. 2000).
Our present studies confirm and extend recent reports
that demonstrated defective genomic imprinting of
GNAS1 as an epigenetic abnormality in patients with
PHP type 1b. An apparent loss of maternal-specific
GNAS1 epigenotype could be caused by paternal uni-
parental disomy of GNAS1, which has been described
in one patient with a PHP type 1b–like syndrome (Bas-
tepe et al. 2001a). Uniparental disomy, as well as de-
letion of maternal GNAS1 sequences, was excluded in
our patients by the demonstration that affected subjects
inherited maternally- and paternally-derived haplotypes
that span the GNAS1 locus (Jan de Beur et al. 2003),
including, in many cases, a 5-bp polymorphism present
within exon 1A, and methylation patterns at the NESP55
and (in nearly all subjects) XLas promoter regions.
A more likely explanation for our findings is a genetic
defect that disturbs the proper establishment of the ma-
ternal-specific methylation imprint at exon 1A and, in
one subject, also at XLas. Linkage analysis suggests that
this defect is tightly linked to the GNAS1 locus on chro-
mosome 20q13 (Juppner et al. 1998; Bastepe et al.
2001b; Jan de Beur et al. 2003), but sequence analysis
of the GNAS1 gene, including the exon 1A region, in
one affected subject from each kindred and in each sub-
ject with sporadic PHP type 1b failed to disclose a het-
erozygous mutation. Thus, it is likely that a cis-acting
mutation is outside the surveyed regions of the imprint-
ing center and is located at some distance from GNAS1
(Bastepe et al. 2001b; Jan de Beur et al. 2003).
Taken in the context of other studies of familial PHP
type 1b (Bastepe et al. 2001b), our observations indicate
that PHP type 1b is caused by mutations that interfere
with the required switch in epigenotype in the germ-
line. Similar cis-acting mutations that disrupt imprinting
at specific loci have been described in several other hu-
man genetic disorders, including Prader-Willi/Angelman
(Horsthemke et al. 1997; Buiting et al. 1998, 2000;
Ohta et al. 1999; Glenn et al. 2000) and Beckwith-
Wiedemann (Lee et al. 1999) syndromes. However, we
are unaware of previous reports of incomplete pene-
trance of an imprinting mutation similar to that iden-
tified in kindred R. The presence of both normal and
abnormal epigenotypes following maternal transmis-
sion of the disease-associated locus (fig. 4) provides ev-
idence for a unique disturbance of the process of imprint
erasure and establishment. This apparent discordance
could arise from segregation of a genetic modifier or be
due to some intrinsic variable expressivity of the gene
defect. We believe that the former explanation is un-
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Table 1
Expression and Methylation Status of Lymphoblast GNAS1Gene
GROUP AND SUBJECT
(DISORDER)
EXPRESSION ATa
METHYLATION
AT EXON 1AbNESP55 XLas Exon 1A Exon 1
Family R:
II.2 (Carrier) NP NP NP NP / B,S
II.4 (PHP1B) NP NP Biallelic NP / B,S
III.1 (PHP1B) NP NP NP NP /S
III.3 (PHP1B) NP NP Biallelic NP / S
III.4 PHP1B) NP NP Biallelic NP / S
II.1 (Unaffected) NP NP NP NP / B,S
II.6 (Unaffected) NP NP Uniallelic NP / S
III.5 (Unaffected) ND ND Uniallelic ND / B
III.6 (Unaffected) ND ND Uniallelic Biallelic ND
III.7 (Unaffected) NP NP NP NP / B
III.8 (Unaffected) ND ND ND ND / B
III.9 (Unaffected) ND ND ND ND / B
IV.1 (Unaffected) ND ND Uniallelic ND / B
IV.2 (Unaffected) ND ND Uniallelic ND / B
Familial PHP1b (N p 17) Uniallelic (4/4) Uniallelic (4/4) Biallelic (5/5) Biallelic (4/4) / (14/14)
Sporadic PHP1b (N p 6) Uniallelic (2/2) Biallelic (1/2) Biallelic (4/4) Biallelic (3/3) / (6/6)
PHP1b carrier (N p 2) Uniallelic (1/1) Uniallelic (1/1) Uniallelic (1/1) Biallelic (1/1) / (2/2)
PHP1a (N p 9) ND ND Uniallelic (5/5) Biallelic (1/1) / (7/7)
Unaffected (N p 20) Uniallelic (1/1) Uniallelic (3/3) Uniallelic (11/11) Biallelic (5/5) / (12/12)
NOTE.—Numbers in parentheses are no. of subjects with expression or no. of subjects with methylation/total no. of
subjects.
a Biallelic p expressed from maternal and paternal allele; ND p not done; NP p noninformative for exon 5
polymorphism; uniallelic p expressed from only one parental allele.
b B p bisulfite sequencing; S p Southern blot analysis; /p absence of methylation demonstrated by sequencing
and/or Southern analysis; / p heterozygous methylation.
likely, because inheritance of a modifier is inconsistent
with observations in the extended pedigree. Rather, it
is more likely that the genetic defect leads to an incon-
sistent failure to erase and properly reset the imprint at
the exon 1A DMR in the germline, thereby leading to
variable inheritance of an inappropriate epigenotype.
Variable expressivity and incomplete parental imprint-
ing have been described in mice carrying an imprinted
transgene (Kearns et al. 2000) as well as at an endog-
enous locus (agouti viable yellow) that has been mod-
ified by insertion of a retroviral element (Wolff et al.
1978; Duhl et al. 1994).
Despite growing knowledge about the genetics of
PHP type 1b, the basis of renal resistance to PTH re-
mains uncertain. The loss of methylation at exon 1A
on the maternal chromosome is associated with biallelic
expression of exon 1A in lymphoblasts and leukocytes.
Although this defect did not alter expression of Gsa
in these cells, in which Gsa transcription remained bial-
lelic, we assume that the maternally inherited imprinting
defect would silence transcription of the Gsa promoter
in paternally imprinted tissues. Under this model, there
should be little or no expression of Gsa in these tissues,
because the presence of paternal-specific imprinting on
both alleles should inhibit transcription from both Gsa
promoters. Support for this proposal derives from the
recent demonstration of reduced Gsa expression in
platelets from a single patient with PHP type 1b (Freson
et al. 2002), as well as from the description of renal
resistance to PTH in a patient with paternal uniparental
isodisomy (Bastepe et al. 2001a). Relaxed paternal im-
printing of Gsa, with continued production of sufficient
Gsa to meet signaling needs, could explain why patients
with PHP type 1b do not generally manifest hormone
resistance in other tissues in which Gsa expression ap-
pears to be paternally imprinted. By contrast, transcrip-
tion of Gsa from both maternal and paternal GNAS1
alleles in other tissues provides an explanation for nor-
mal levels of Gsa in erythrocytes from patients with PHP
type 1b and for a similar 50% reduction in Gsa in pa-
tients with PHP type 1a or PPHP, who have mutations
on maternal or paternal alleles, respectively (Farfel et
al. 1980b; Levine et al. 1980, 1986).
In conclusion, our data indicate that the epigenetic
defect, not the putative genetic mutation, accounts for
PTH resistance in subjects with PHP type 1b. Moreover,
to our knowledge, kindred R represents the first dem-
onstration of incomplete expression of a reprogramming
defect that affects imprinting, and the observations pre-
sented here suggest that accurate genetic diagnosis of PHP
type 1b should be based on methylation analysis rather
than haplotype analysis. The identification of the genetic
320 Am. J. Hum. Genet. 73:314–322, 2003
Figure 4 Family R pedigree. Unaffected individuals are indicated by an open circle (female) or square (male). An individual carrying the
defective PHP type 1b allele is indicated by a blackened upper left quadrant of the symbol; PTH resistance is indicated by a blackened lower
right quadrant; normal imprinting is indicated by a blackened lower left quadrant; loss of maternal imprinting is indicated by a blackened
upper right quadrant. NTp not tested. Imprinting of exon 1A was determined by restriction endonuclease digestion using methylation sensitive
enzymes or by bisulfite sequencing (see text).
defect(s) in subjects with PHP type 1b, particularly the
affected members of kindred R, will be important to our
understanding of the genetics of PHP type 1b, as well as
the mechanism of genomic imprinting.
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